Table 1.

Patients with high BCL2 and/or high MYC expression according to treatment arm and age

n (%)	Ibrutinib + R-CHOP (n = 386)	Placebo + R-CHOP (n = 380)
All ages
BCL2-high	196 (50.8)	187 (49.2)
MYC-high	199 (51.6)	183 (48.2)
MYC-high + BCL2-high	123 (31.9)	111 (29.2)
<60 y
n	149	168
MYC-high + BCL2-high	47 (31.5)	50 (29.8)
≥60 y
n	237	212
MYC-high + BCL2-high	76 (32.1)	61 (28.8)